Three doses over six months; two for some adolescents.
RECOMBIVAX HB is listed under Health Canada DIN 02561476. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
At a glance
Brand
RECOMBIVAX HB
DIN
02561476
Vaccine
Hepatitis B surface antigen (recombinant)
Presentation
5 mcg / 0.5 mL · solution · intramuscular · birth to 19 years
Live vaccine
No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Official sources
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
Before and after your vaccination
Bring your immunization record if you have one, so earlier doses can be checked.
Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
Keep a record of the vaccine name, date and dose you received.
For product-specific effects and precautions, check this DIN in the Health Canada product record and monograph. The general appointment steps above apply to all vaccinations.
No directly matching Pharmasist product guide was identified for this DIN. Use the linked Health Canada record to check your exact product.
Dose schedules
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
Hepatitis B — standard three-dose series
3 doses
Standard hepatitis B series at months 0, 1 and 6.
Minimum intervals: 4 weeks between doses 1 and 2, 2 months between doses 2 and 3, and 4 months between doses 1 and 3. The age-appropriate product and dose are chosen by your healthcare professional; blood testing after the series is needed for some people.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.